Active Giant Cell Vasculitis Diagnosis with 68Ga PSMA PET/CT Imaging

1. Chun AR, Jo HM, Lee SH, Chun HW, Park JM, Kim KJ, Jung CH, Mok JO, Kang SK, Kim CH, Kim BY. Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography. EndocrinolMetab (Seoul) 2015;30:71-77.
2. Giovacchini G, Giovannini E, Riondato M, Ciarmiello A. PET/CT With 68Ga-PSMA in Prostate Cancer: Radiopharmaceutical Background and Clinical Implications. Curr Radiopharm 2018;11:4-13.
3. Malik D, Kumar R, Mittal BR, Singh H, Bhattacharya A, Singh SK. 68Ga-Labeled PSMA Uptake in Nonprostatic Malignancies: Has the Time Come to Remove “PS” From PSMA? Clin Nucl Med 2018;43:529-532.
4. Treglia G, Mattoli MV, Leccisotti L, Ferraccioli G, Giordano A. Usefulness of whole-body fluorine-18-fluorodeoxyglucose positron emission tomography in patients with large-vessel vasculitis: a systematic review. Clin Rheumatol 2011;30: 1265-1275.
5. Balink H, Bennink RJ, van Eck-Smit BL, Verberne HJ. The role of 18F-FDG PET/CT in large-vessel vasculitis: appropriateness of current classification criteria? Biomed Res Int 2014;2014:687608.

APA	SAGER S, Bilgiç S, USLU BESLI R, Asa S, sager s, Sonmezoglu K (2021). Active Giant Cell Vasculitis Diagnosis with 68Ga PSMA PET/CT Imaging. , 57 - 59. 10.4274/mirt.galenos.2019.90532
Chicago	SAGER Sait,Bilgiç Seçkin,USLU BESLI RABİA LEBRIZ,Asa Sertac,sager safiye gunes,Sonmezoglu Kerim Active Giant Cell Vasculitis Diagnosis with 68Ga PSMA PET/CT Imaging. (2021): 57 - 59. 10.4274/mirt.galenos.2019.90532
MLA	SAGER Sait,Bilgiç Seçkin,USLU BESLI RABİA LEBRIZ,Asa Sertac,sager safiye gunes,Sonmezoglu Kerim Active Giant Cell Vasculitis Diagnosis with 68Ga PSMA PET/CT Imaging. , 2021, ss.57 - 59. 10.4274/mirt.galenos.2019.90532
AMA	SAGER S,Bilgiç S,USLU BESLI R,Asa S,sager s,Sonmezoglu K Active Giant Cell Vasculitis Diagnosis with 68Ga PSMA PET/CT Imaging. . 2021; 57 - 59. 10.4274/mirt.galenos.2019.90532
Vancouver	SAGER S,Bilgiç S,USLU BESLI R,Asa S,sager s,Sonmezoglu K Active Giant Cell Vasculitis Diagnosis with 68Ga PSMA PET/CT Imaging. . 2021; 57 - 59. 10.4274/mirt.galenos.2019.90532
IEEE	SAGER S,Bilgiç S,USLU BESLI R,Asa S,sager s,Sonmezoglu K "Active Giant Cell Vasculitis Diagnosis with 68Ga PSMA PET/CT Imaging." , ss.57 - 59, 2021. 10.4274/mirt.galenos.2019.90532
ISNAD	SAGER, Sait vd. "Active Giant Cell Vasculitis Diagnosis with 68Ga PSMA PET/CT Imaging". (2021), 57-59. https://doi.org/10.4274/mirt.galenos.2019.90532

APA	SAGER S, Bilgiç S, USLU BESLI R, Asa S, sager s, Sonmezoglu K (2021). Active Giant Cell Vasculitis Diagnosis with 68Ga PSMA PET/CT Imaging. Molecular Imaging and Radionuclide Therapy, 30(1), 57 - 59. 10.4274/mirt.galenos.2019.90532
Chicago	SAGER Sait,Bilgiç Seçkin,USLU BESLI RABİA LEBRIZ,Asa Sertac,sager safiye gunes,Sonmezoglu Kerim Active Giant Cell Vasculitis Diagnosis with 68Ga PSMA PET/CT Imaging. Molecular Imaging and Radionuclide Therapy 30, no.1 (2021): 57 - 59. 10.4274/mirt.galenos.2019.90532
MLA	SAGER Sait,Bilgiç Seçkin,USLU BESLI RABİA LEBRIZ,Asa Sertac,sager safiye gunes,Sonmezoglu Kerim Active Giant Cell Vasculitis Diagnosis with 68Ga PSMA PET/CT Imaging. Molecular Imaging and Radionuclide Therapy, vol.30, no.1, 2021, ss.57 - 59. 10.4274/mirt.galenos.2019.90532
AMA	SAGER S,Bilgiç S,USLU BESLI R,Asa S,sager s,Sonmezoglu K Active Giant Cell Vasculitis Diagnosis with 68Ga PSMA PET/CT Imaging. Molecular Imaging and Radionuclide Therapy. 2021; 30(1): 57 - 59. 10.4274/mirt.galenos.2019.90532
Vancouver	SAGER S,Bilgiç S,USLU BESLI R,Asa S,sager s,Sonmezoglu K Active Giant Cell Vasculitis Diagnosis with 68Ga PSMA PET/CT Imaging. Molecular Imaging and Radionuclide Therapy. 2021; 30(1): 57 - 59. 10.4274/mirt.galenos.2019.90532
IEEE	SAGER S,Bilgiç S,USLU BESLI R,Asa S,sager s,Sonmezoglu K "Active Giant Cell Vasculitis Diagnosis with 68Ga PSMA PET/CT Imaging." Molecular Imaging and Radionuclide Therapy, 30, ss.57 - 59, 2021. 10.4274/mirt.galenos.2019.90532
ISNAD	SAGER, Sait vd. "Active Giant Cell Vasculitis Diagnosis with 68Ga PSMA PET/CT Imaging". Molecular Imaging and Radionuclide Therapy 30/1 (2021), 57-59. https://doi.org/10.4274/mirt.galenos.2019.90532